Costello, Inc. – Trademark Portfolio
Entity Type: 03
Costello, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include 7 GEN PLANNING. The owner is based in Houston, TX.
2107 CityWest Blvd., 3rd Floor
Houston, TX 77042
Showing of trademarks Trademarks
Trademark Classifications
Costello, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Costello, Inc. have?
Costello, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Costello, Inc. file in?
Costello, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 37 covers building construction; repair; installation services.
What are Costello, Inc.'s most well-known trademarks?
Costello, Inc.'s registered trademark portfolio includes well-known marks such as 7 GEN PLANNING. These are among 3 currently registered trademarks in the portfolio.
What is Costello, Inc.'s trademark registration success rate?
Costello, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.